Collaborative Effort Leads to Potential New Class of Drugs for Crohn’s Disease and Other Autoimmune Disorders

Collaborative Effort Leads to Potential New Class of Drugs for Crohn’s Disease and Other Autoimmune Disorders
A joint effort between researchers at Merck Research Laboratories (named MSD outside the U.S. and Canada), Eindhoven University of Technology (TU/e) and Leiden University, both in The Netherlands, has led to the discovery of a completely new way to block a human nuclear receptor, with possible implications for Crohn’s disease. The study, entitled “Identification of

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *